$Cassava Sciences (SAVA.US)$ New SAVA Update April 25th , 20...
$Cassava Sciences(SAVA.US$ New SAVA Update April 25th , 2024 on Clinical Trials. Open-label Study of the Absorption, Metabolism, and Excretion" for SAVA's promising Phase 3 #Alzheimers drug candidate is now complete. - Thanks Archisaurus !
![$Cassava Sciences (SAVA.US)$ New SAVA Update April 25th , 2024 on Clinical Trials. Open-label Study of the Absorption, Metabolism, and Excretion" for SAVA's pro...](https://ussnsimg.moomoo.com/sns_client_feed/71846513/20240430/c8e6525d1ea5175b43e820b90765bed0.jpg/big?area=100&is_public=true)
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
HolyPotatoe : So what does that mean to the stock? Doesn’t look like it’s going anywhere?